logo

Centre of Evidence of Dermatology Best practice guidelines

Guidelines classic scabies: in children < 15kg, pregnant or breastfeeding women Updated on january 2024

Responsibility


The information provided by this website comes from sources deemed reliable. However, the French Dermatology Society recommends that the user ensure the validity of this information. Some may prove to be erroneous or be subject to typos or display errors.

The use of this data is under the sole responsibility of the user. The French Dermatology Society cannot be blamed for a misinterpretation of the data provided by the site, or in the event of erroneous information. This decision tree and all the contents of this site have been developed in the context of updated data from science according to the HAS methodology, expert opinions and reviewers of the various documents and in the context of the French healthcare system.


Context and objectives of these guidelines

Back to decision-making tree Print last updated on 10/06/2024

Goal

Recommendations for the management of Scabies in children (< 15kg) are developed by the Center for Evidence in Dermatology with the aim of providing professionals caring for these patients with decision-making tools.

They are intended to facilitate the diagnostic and therapeutic approach to this condition in view of the benefit/risk ratio of available treatments, many of which are used without marketing authorization. They will evolve based on new scientific data in the coming years: additional studies are expected to compare the cluster effectiveness of permethrin cream vs. Ivermectin.

Patients affected by these recommendations

Patients with classic scabies: children under 5 years old, pregnant or breastfeeding women, and contacts.

First recommendations for the management of scabies in children under 5 years old and pregnant or breastfeeding women.

Although the level of scientific evidence is limited, this work confirms the good tolerance and effectiveness of scabicide treatments in this particular population.

In certain situations, the off-label use of oral ivermectin is suggested.

Professionals concerned

The professionals involved are healthcare personnel caring for patients with scabies, including dermatologists, infectious disease specialists, general practitioners, as well as emergency physicians, internists, gynecologists, pediatricians, and nurses involved in this pathology.

Working group

A working group has been formed.
It includes:

The presidents coordinated the work of the group; the project leader identified, selected, and coordinated the writing of the argument. The writing of the scientific argument was based on the critical analysis and synthesis of the literature (all members of the working group).


back to decision-making tree

  • Was this article helpful to you?
  • Your opinion counts!

    This notice will not be published on this site, but only sent to the publication management. Your email will only be used to reply to you if we deem it necessary. No response will be sent to any request for medical advice via this form.


definition

Centre of Evidence of Dermatology Centre of Evidence of Dermatology logo
Work
10 cité Malesherbes
75009Paris
Île-de-France
FRANCE
Work +33.1 43 27 01 56
Fax +33.1 43 27 01 86
centredepreuvesdermato@sfdermato.org